Literature DB >> 20428391

Outcomes of antiretroviral therapy in a northern Indian urban clinic.

Surendra K Sharma1, Sahajal Dhooria, K T Prasad, Ninoo George, Sanjay Ranjan, Deepak Gupta, Vishnubhatla Sreenivas, Tamilarasu Kadhiravan, Sunita Miglani, Sanjeev Sinha, Naveet Wig, Ashutosh Biswas, Madhu Vajpayee.   

Abstract

PROBLEM: Antiretroviral therapy (ART) programmes have been successful in several countries. However, whether they would succeed as part of a national programme in a resource-constrained setting such as India is not clear. The outcomes and specific problems encountered in such a setting have not been adequately studied. APPROACH: We assessed the efficacy and functioning of India's national ART programme in a tertiary care centre in northern India. All ART-naive patients started on ART between May 2005 and October 2006 were included in the study and were followed until 31 April 2008. Periodic clinical and laboratory evaluations were carried out in accordance with national guidelines. Changes in CD4+ lymphocyte count, body weight and body mass index were assessed at follow-up, and the operational problems analysed. LOCAL
SETTING: The setting was a tertiary care centre in northern India with a mixed population of patients, mostly of low socioeconomic status. The centre is reasonably well resourced but faces constraints in health-care delivery, such as lack of adequate human resources and a high patient load. RELEVANT CHANGES: The response to ART in the cohort studied was comparable to that reported from other countries. However, the programme had a high attrition rate, possibly due to patient-related factors and operational constraints. LESSONS LEARNT: A high rate of attrition can affect the overall efficacy and functioning of an ART programme. Addressing the issues causing attrition might improve patient outcomes in India and in other resource-constrained countries.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20428391      PMCID: PMC2828789          DOI: 10.2471/BLT.09.068759

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  8 in total

1.  Impact of pulmonary tuberculosis on survival of HIV-infected adults: a prospective epidemiologic study in Uganda.

Authors:  C C Whalen; P Nsubuga; A Okwera; J L Johnson; D L Hom; N L Michael; R D Mugerwa; J J Ellner
Journal:  AIDS       Date:  2000-06-16       Impact factor: 4.177

2.  Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.

Authors:  F J Palella; K M Delaney; A C Moorman; M O Loveless; J Fuhrer; G A Satten; D J Aschman; S D Holmberg
Journal:  N Engl J Med       Date:  1998-03-26       Impact factor: 91.245

3.  Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes.

Authors:  Jeffrey S A Stringer; Isaac Zulu; Jens Levy; Elizabeth M Stringer; Albert Mwango; Benjamin H Chi; Vilepe Mtonga; Stewart Reid; Ronald A Cantrell; Marc Bulterys; Michael S Saag; Richard G Marlink; Alwyn Mwinga; Tedd V Ellerbrock; Moses Sinkala
Journal:  JAMA       Date:  2006-08-16       Impact factor: 56.272

4.  Antiretroviral therapy in a thousand patients with AIDS in Haiti.

Authors:  Patrice Severe; Paul Leger; Macarthur Charles; Francine Noel; Gerry Bonhomme; Gyrlande Bois; Erik George; Stefan Kenel-Pierre; Peter F Wright; Roy Gulick; Warren D Johnson; Jean William Pape; Daniel W Fitzgerald
Journal:  N Engl J Med       Date:  2005-12-01       Impact factor: 91.245

5.  Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group.

Authors:  A Mocroft; S Vella; T L Benfield; A Chiesi; V Miller; P Gargalianos; A d'Arminio Monforte; I Yust; J N Bruun; A N Phillips; J D Lundgren
Journal:  Lancet       Date:  1998-11-28       Impact factor: 79.321

6.  Adherence to antiretroviral therapy & its determinants amongst HIV patients in India.

Authors:  A Sarna; S Pujari; A K Sengar; R Garg; I Gupta; J van Dam
Journal:  Indian J Med Res       Date:  2008-01       Impact factor: 2.375

7.  Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries.

Authors:  Paula Braitstein; Martin W G Brinkhof; François Dabis; Mauro Schechter; Andrew Boulle; Paolo Miotti; Robin Wood; Christian Laurent; Eduardo Sprinz; Catherine Seyler; David R Bangsberg; Eric Balestre; Jonathan A C Sterne; Margaret May; Matthias Egger
Journal:  Lancet       Date:  2006-03-11       Impact factor: 79.321

8.  Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis.

Authors:  Martin W G Brinkhof; Mar Pujades-Rodriguez; Matthias Egger
Journal:  PLoS One       Date:  2009-06-04       Impact factor: 3.240

  8 in total
  18 in total

1.  The challenge of communicable diseases in the WHO South-East Asia Region.

Authors:  Jai P Narain; R Bhatia
Journal:  Bull World Health Organ       Date:  2010-03       Impact factor: 9.408

2.  Impact of a rural village women (Asha) intervention on adherence to antiretroviral therapy in southern India.

Authors:  Adeline Nyamathi; Alecia Y Hanson; Benissa E Salem; Sanjeev Sinha; Kalyan K Ganguly; Barbara Leake; Kartik Yadav; Mary Marfisee
Journal:  Nurs Res       Date:  2012 Sep-Oct       Impact factor: 2.381

3.  Predictors of first line antiretroviral therapy failure and burden of second line antiretroviral therapy.

Authors:  Seema Patrikar; Subramanian Shankar; Atul Kotwal; D R Basannar; Vijay Bhatti; Rajesh Verma; Sandip Mukherji
Journal:  Med J Armed Forces India       Date:  2016-12-01

4.  Toxicity and clinical outcomes in patients with HIV on zidovudine and tenofovir based regimens: a retrospective cohort study.

Authors:  Sowmyanarayanan V Thuppal; Christine A Wanke; Farzad Noubary; Joshua T Cohen; Mkaya Mwamburi; Abraham C Ooriapdickal; Jayaprakash Muliyil; Gagandeep Kang; George M Varghese; Priscilla Rupali; Rajiv Karthik; Rajkumar Sathasivam; Peace Clarance; Susanne A Pulimood; Dincy Peter; Leni George
Journal:  Trans R Soc Trop Med Hyg       Date:  2015-03-15       Impact factor: 2.184

Review 5.  Effects of physical tracing on estimates of loss to follow-up, mortality and retention in low and middle income country antiretroviral therapy programs: a systematic review.

Authors:  James H McMahon; Julian H Elliott; Steven Y Hong; Silvia Bertagnolio; Michael R Jordan
Journal:  PLoS One       Date:  2013-02-12       Impact factor: 3.240

6.  The growing challenge of antimicrobial resistance in the South-East Asia Region--are we losing the battle?

Authors:  Rajesh Bhatia; Jai P Narain
Journal:  Indian J Med Res       Date:  2010-11       Impact factor: 2.375

7.  Clinical characteristics of tuberculosis-associated immune reconstitution inflammatory syndrome in North Indian population of HIV/AIDS patients receiving HAART.

Authors:  Suman Karmakar; Surendra K Sharma; Richa Vashishtha; Abhishek Sharma; Sanjay Ranjan; Deepak Gupta; Vishnubhatla Sreenivas; Sanjeev Sinha; Ashutosh Biswas; Vinay Gulati
Journal:  Clin Dev Immunol       Date:  2010-12-01

8.  Retention of antiretroviral naïve patients registered in HIV care in a program clinic in Pune, India.

Authors:  Manisha V Ghate; Sunil S Zirpe; Nilam P Gurav; Bharat B Rewari; Raman R Gangakhedkar; Ramesh S Paranjape
Journal:  Indian J Sex Transm Dis AIDS       Date:  2014 Jul-Dec

9.  Progressive multifocal leucoencephalopathy in HIV/AIDS: observational study from a tertiary care centre in northern India.

Authors:  S K Sharma; M Soneja; S Ranjan; S Miglani; S Hari; S Sinha; N Wig
Journal:  Indian J Med Res       Date:  2013       Impact factor: 2.375

10.  Efficacy and safety of thrice weekly DOTS in tuberculosis patients with and without HIV co-infection: an observational study.

Authors:  Richa Vashishtha; Krishna Mohan; Bhagteshwar Singh; Satish K Devarapu; Vishnubhatla Sreenivas; Sanjay Ranjan; Deepak Gupta; Sanjeev Sinha; Surendra K Sharma
Journal:  BMC Infect Dis       Date:  2013-10-07       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.